Coda Octopus Group has appointed Mark Kelly as its new permanent CFO, effective August 3, 2026, succeeding interim CFO Gayle Jardine who will retire on the same date. The transition includes an initial three-month probationary period, which the company may extend by an additional two months. Kelly's experience includes serving as Finance Director at Medac Pharma from 2024 to 2025, Head of Glasgow Finance at Chubb Insurance from 2022 to 2024, and Finance Director at Twist Bioscience Corp. prior to that. He will receive an annual base salary of £165,000, approximately $218,625, along with eligibility for discretionary annual performance bonuses and a $40,000 restricted stock grant vesting in two equal annual installments beginning October 31, 2027, contingent on performance milestones.
Coda Octopus Group IncAppointment of a new CFO with relevant experience, providing leadership stability.
Chubb Ltd
Twist Bioscience Corp